Sphera Funds Management Ltd. Teva Pharmaceutical Industries LTD Transaction History

Sphera Funds Management Ltd.

$380 Million
Q1 2025

A detailed history of Sphera Funds Management Ltd. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 1,572,181 shares of TEVA stock, worth $26.2 Million. This represents 6.36% of its overall portfolio holdings.

Number of Shares

1,572,181

Previous 1,569,181 0.19%

Holding current value

$26.2 Million

Previous $34.6 Million 30.13%

% of portfolio

6.36%

Previous 7.12%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$14.67 - $22.01 $44,010 - $66,030	3,000 Added 0.19%	1,572,181 $24.2 Million
Q4 2024 Feb 14, 2025	SELL	$16.43 - $22.77 $9.22 Million - $12.8 Million	-561,035 Reduced 26.34%	1,569,181 $34.6 Million
Q3 2024 Nov 14, 2024	BUY	$15.81 - $18.96 $21.2 Million - $25.4 Million	1,340,800 Added 169.85%	2,130,216 $38.4 Million
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $14.1 Million - $19.1 Million	-1,100,284 Reduced 58.23%	789,416 $12.8 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $6.18 Million - $8.36 Million	-579,400 Reduced 23.47%	1,889,700 $26.7 Million
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $15.2 Million - $19.9 Million	1,869,100 Added 311.52%	2,469,100 $25.8 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $3.37 Million - $4.82 Million	-450,000 Reduced 42.86%	600,000 $6.12 Million
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $7.12 Million - $9.37 Million	-989,500 Reduced 48.52%	1,050,000 $7.91 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $17.1 Million - $23.2 Million	2,039,500 New	2,039,500 $18 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $2.55 Million - $4.44 Million	-371,532 Reduced 32.37%	776,346 $6.27 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $2.32 Million - $3.28 Million	315,000 Added 37.82%	1,147,878 $8.63 Million
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $7 - $9	1 Added 0.0%	832,878 $7.82 Million
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $7 - $10	-1 Reduced -0.0%	832,877 $6.67 Million
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $6.46 Million - $8.28 Million	-750,000 Reduced 47.38%	832,878 $8.04 Million
Q3 2020 Nov 12, 2020	BUY	$8.57 - $12.69 $8.57 Million - $12.7 Million	1,000,000 Added 171.56%	1,582,878 $14.3 Million
Q2 2020 Aug 13, 2020	BUY	$8.12 - $13.12 $1.84 Million - $2.97 Million	226,165 Added 63.4%	582,878 $7.19 Million
Q1 2020 May 14, 2020	BUY	$6.69 - $13.45 $644,655 - $1.3 Million	96,361 Added 37.01%	356,713 $3.2 Million
Q4 2019 Feb 13, 2020	SELL	$6.53 - $10.72 $8.42 Million - $13.8 Million	-1,289,648 Reduced 83.2%	260,352 $2.55 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $4.66 Million - $7.26 Million	756,166 Added 95.25%	1,550,000 $10.7 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $6.01 Million - $11.6 Million	740,000 Added 1374.6%	793,834 $0
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $10.1 Million - $13 Million	-650,666 Reduced 92.36%	53,834 $844,000
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $7.36 Million - $12 Million	504,500 Added 252.25%	704,500 $10.9 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $4.21 Million - $5.13 Million	200,000 New	200,000 $4.31 Million
Q1 2018 May 10, 2018	SELL	$16.68 - $22.07 $1.98 Million - $2.62 Million	-118,750 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$11.23 - $19.1 $3.16 Million - $5.37 Million	-281,250 Reduced 70.31%	118,750 $2.25 Million
Q3 2017 Nov 09, 2017	BUY	$15.41 - $32.17 $6.16 Million - $12.9 Million	400,000	400,000 $7.04 Million

Others Institutions Holding TEVA

# of Institutions

660

Shares Held

626M

Call Options Held

27.9M

Put Options Held

21.8M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Teva Pharmaceutical Industries LTD Transaction History